| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Avenue Therapeutics Inc (NASDAQ: ATXI)
ATXI Technical Analysis
2.5
| As on 9th Jun 2023 ATXI STOCK Price closed @ 1.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.02 & Strong Buy for SHORT-TERM with Stoploss of 0.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATXISTOCK Price
| Open | 1.17 | Change | Price | % |
| High | 1.19 | 1 Day | -0.03 | -2.54 |
| Low | 1.14 | 1 Week | 0.07 | 6.48 |
| Close | 1.15 | 1 Month | 0.20 | 21.05 |
| Volume | 79200 | 1 Year | 0.20 | 21.05 |
| 52 Week High 14.50 | 52 Week Low 0.21 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATXI Daily Charts |
ATXI Intraday Charts |
Whats New @ Bazaartrend |
ATXI Free Analysis |
|
|
ATXI Important Levels Intraday
| RESISTANCE | 1.25 |
| RESISTANCE | 1.22 |
| RESISTANCE | 1.20 |
| RESISTANCE | 1.18 |
| SUPPORT | 1.12 |
| SUPPORT | 1.10 |
| SUPPORT | 1.08 |
| SUPPORT | 1.05 |
ATXI Forecast April 2024
| 4th UP Forecast | 2.4 |
| 3rd UP Forecast | 2 |
| 2nd UP Forecast | 1.75 |
| 1st UP Forecast | 1.5 |
| 1st DOWN Forecast | 0.8 |
| 2nd DOWN Forecast | 0.55 |
| 3rd DOWN Forecast | 0.3 |
| 4th DOWN Forecast | -0.1 |
ATXI Weekly Forecast
| 4th UP Forecast | 1.44 |
| 3rd UP Forecast | 1.35 |
| 2nd UP Forecast | 1.29 |
| 1st UP Forecast | 1.23 |
| 1st DOWN Forecast | 1.07 |
| 2nd DOWN Forecast | 1.01 |
| 3rd DOWN Forecast | 0.95 |
| 4th DOWN Forecast | 0.86 |
ATXI Forecast2024
| 4th UP Forecast | 32.85 |
| 3rd UP Forecast | 22.68 |
| 2nd UP Forecast | 16.4 |
| 1st UP Forecast | 10.12 |
| 1st DOWN Forecast | -7.82 |
| 2nd DOWN Forecast | -14.1 |
| 3rd DOWN Forecast | -20.38 |
| 4th DOWN Forecast | -30.55 |
Avenue Therapeutics Inc ( NASDAQ USA Symbol : ATXI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATXI Business Profile
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York. Address: 1140 Avenue of the America, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service